246 related articles for article (PubMed ID: 37747577)
1. Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease.
Nieto M; Konigsberg M; Silva-Palacios A
Biogerontology; 2024 Feb; 25(1):71-82. PubMed ID: 37747577
[TBL] [Abstract][Full Text] [Related]
2. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
[TBL] [Abstract][Full Text] [Related]
3. Senolytics Cocktail Dasatinib and Quercetin Alleviate Human Umbilical Vein Endothelial Cell Senescence via the TRAF6-MAPK-NF-κB Axis in a YTHDF2-Dependent Manner.
Fan T; Du Y; Zhang M; Zhu AR; Zhang J
Gerontology; 2022; 68(8):920-934. PubMed ID: 35468611
[TBL] [Abstract][Full Text] [Related]
4. Potential Clinical Implications of Senotherapies for Cardiovascular Disease.
Suda M; Katsuumi G; Tchkonia T; Kirkland JL; Minamino T
Circ J; 2024 Feb; 88(3):277-284. PubMed ID: 37880106
[TBL] [Abstract][Full Text] [Related]
5. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
[TBL] [Abstract][Full Text] [Related]
6. Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
Xing X; Tang Q; Zou J; Huang H; Yang J; Gao X; Xu X; Ma S; Li M; Liang C; Tan L; Liao L; Tian W
Acta Biomater; 2023 Feb; 157():352-366. PubMed ID: 36470392
[TBL] [Abstract][Full Text] [Related]
7. Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation.
Wyles SP; Tchkonia T; Kirkland JL
Plast Reconstr Surg; 2022 Oct; 150():20S-26S. PubMed ID: 36170432
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice.
Pastor-Fernández A; Bertos AR; Sierra-Ramírez A; Del Moral-Salmoral J; Merino J; de Ávila AI; Olagüe C; Villares R; González-Aseguinolaza G; Rodríguez MÁ; Fresno M; Gironés N; Bustos M; Smerdou C; Fernandez-Marcos PJ; von Kobbe C
Aging Cell; 2023 Mar; 22(3):e13771. PubMed ID: 36704839
[TBL] [Abstract][Full Text] [Related]
9. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
Chandrakar L; Ambatwar R; Khatik GL
Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological clearance of senescent cells improves cardiac remodeling and function after myocardial infarction in female aged mice.
Salerno N; Marino F; Scalise M; Salerno L; Molinaro C; Filardo A; Chiefalo A; Panuccio G; De Angelis A; Urbanek K; Torella D; Cianflone E
Mech Ageing Dev; 2022 Dec; 208():111740. PubMed ID: 36150603
[TBL] [Abstract][Full Text] [Related]
11. Senolytic drugs dasatinib and quercetin combined with Carboplatin or Olaparib reduced the peritoneal and adipose tissue metastasis of ovarian cancer.
Wang L; Xiong B; Lu W; Cheng Y; Zhu J; Ai G; Zhang X; Liu X; Cheng Z
Biomed Pharmacother; 2024 May; 174():116474. PubMed ID: 38518604
[TBL] [Abstract][Full Text] [Related]
12. Induction of Cellular Senescence in Rat Vaginal Fibroblasts and Treatment With Senolytics: An in Vitro Model for the Study of Pelvic Organ Prolapse.
Florian-Rodriguez ME; Hare AM; Gaddam NG; Shi H; Keller P; Word RA
Female Pelvic Med Reconstr Surg; 2022 May; 28(5):341-345. PubMed ID: 35030138
[TBL] [Abstract][Full Text] [Related]
13. Senolytic treatment reverses obesity-mediated senescent cell accumulation in the ovary.
Hense JD; Garcia DN; Isola JV; Alvarado-Rincón JA; Zanini BM; Prosczek JB; Stout MB; Mason JB; Walsh PT; Brieño-Enríquez MA; Schadock I; Barros CC; Masternak MM; Schneider A
Geroscience; 2022 Jun; 44(3):1747-1759. PubMed ID: 35460445
[TBL] [Abstract][Full Text] [Related]
14. Senescence-mediated anticancer effects of quercetin.
Özsoy Gökbilen S; Becer E; Vatansever HS
Nutr Res; 2022 Aug; 104():82-90. PubMed ID: 35635900
[TBL] [Abstract][Full Text] [Related]
15. Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics.
Gao Y; Wu T; Tang X; Wen J; Zhang Y; Zhang J; Wang S
Geroscience; 2023 Jun; 45(3):1775-1790. PubMed ID: 36648735
[TBL] [Abstract][Full Text] [Related]
16. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
17. Senolytics ameliorate the failure of bone regeneration through the cell senescence-related inflammatory signalling pathway.
Wang X; Zhou Y; Luo C; Zhao J; Ji Y; Wang Z; Zheng P; Li D; Shi Y; Nishiura A; Matsumoto N; Honda Y; Xu B; Huang F
Biomed Pharmacother; 2024 Jun; 175():116606. PubMed ID: 38670048
[TBL] [Abstract][Full Text] [Related]
18. Computational identification of natural senotherapeutic compounds that mimic dasatinib based on gene expression data.
Meiners F; Hinz B; Boeckmann L; Secci R; Sueto S; Kuepfer L; Fuellen G; Barrantes I
Sci Rep; 2024 Mar; 14(1):6286. PubMed ID: 38491064
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Senolytics in Cardiovascular Disease.
Dookun E; Passos JF; Arthur HM; Richardson GD
Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
[TBL] [Abstract][Full Text] [Related]
20. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age.
Islam MT; Tuday E; Allen S; Kim J; Trott DW; Holland WL; Donato AJ; Lesniewski LA
Aging Cell; 2023 Feb; 22(2):e13767. PubMed ID: 36637079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
